Skip to content
Medical Health Aged Care

One in three women have a baby in their first IVF cycle: report

UNSW Sydney 4 mins read

The annual IVF report from UNSW reveals the latest numbers and trends in assisted reproductive technology. 

One in three women successfully have a baby in their first IVF cycle, a new report by UNSW Sydney medical researchers shows. 

The 2021 Australian and New Zealand Assisted Reproduction Database (ANZARD) report – the most recent year for which complete IVF data is available – found 37.1% of women who commenced Assisted Reproductive Technology (ART) achieved a live birth in their first complete ART cycle. The annual IVF report also showed women had at least a 53.6% chance of achieving a live birth after three complete ART cycles. 

ART success rates decreased with age. Women aged between 30 and 34 had at least a 67.8% chance of achieving a live birth after three complete ART cycles, while women aged 40-44 had at least a 20.3% chance. 

“These estimates can be used when counselling women about their likelihood of having a baby using ART treatment and to inform public policy,” says Professor Georgina Chambers, lead author of the report and Director of the National Perinatal Epidemiology and Statistics Unit at UNSW Medicine & Health

ART is a group of procedures that involve the in vitro (outside of the body) handling of oocytes (eggs) and sperm to establish a pregnancy. Each ART treatment involves several stages, generally called an ART treatment cycle. The embryos transferred to a female patient can either originate from the cycle in which they were created (fresh cycle) or be frozen (cryopreserved) and thawed before transfer (thaw cycle). A complete ART cycle includes embryos transferred during the embryo creation cycle and any subsequent frozen embryo transfer cycles. 

“Cumulative longitudinal birth rates based on complete ART cycles are meaningful estimates of the success of ART treatment, reflecting contemporary clinical practice and encouraging safe embryo transfer practices,” says Prof. Chambers.

The report also showed that, on average, one in four women did not continue treatment after a failed cycle.

“There are many reasons why women elect not to continue treatment, including the psychological, physiological and financial stress that can be associated with infertility and its treatment,” says Professor Luk Rombauts, the President of the Fertility Society of Australia and New Zealand (FSANZ), which funds the annual ANZARD report.

Record number of IVF births

In 2021, 111,253 ART treatment cycles were performed in Australia and New Zealand resulting in the birth of 20,690 babies, a record high for IVF medical treatments. From 2020, this represents an increase in cycles of 17.1% in Australia and 7.1% in New Zealand and a 12% increase in the number of babies born following IVF treatment. One in 18 children born in Australia and one in 27 born in New Zealand were conceived through ART treatment.

“With over 20,000 babies born through these treatments, it's evident that ART is a significant contributor to our nation's growth and a testament to the resilience and determination of those seeking to build their families,” says Prof. Rombauts.

In 2021, there were a total of 5881 fertility preservation cycles conducted, a 61.5% increase on 2020. These cycles involve freezing all suitable eggs or embryos for future use. Notably, 10.5% of these cycles were for women preserving their fertility due to a cancer diagnosis, with the remaining for other medical or non-medical reasons.

“The rise in elective egg freezing is something that has been observed globally as a means for women to extend their fertility,” says Prof. Rombauts.

The proportion of embryo transfer cycles that used embryos fertilised using intracytoplasmic sperm injection (ICSI) continued to decrease, from 62.2% in 2017 to 55.6% in 2021.

Dr Petra Wale, a senior embryologist and Vice President of FSANZ explains the ICSI technique was originally developed to address male infertility issues.

“It was designed to assist couples where the male partner had problems with sperm quality, quantity, or motility, making it difficult for natural fertilisation to occur,” Dr Wale says. “ICSI involves injecting a single sperm directly into an egg to facilitate fertilisation, overcoming some of the challenges associated with male infertility.

“Its reduced utilization shows the sector is responding to emerging evidence indicating that ICSI may not yield discernible benefits for couples without male infertility issues.”

The YourIVFSuccess website produced by UNSW, which includes an IVF Success Estimator and a searchable database of the success rates for all accredited IVF clinics in Australia, will be updated later this year to include more recent IVF clinic success rates. The estimator will be updated to include relevance for single women, LGBTQI+ and those contemplating using donor eggs or sperm.

The ANZARD report contains data from all 95 IVF clinics operating in Australia and New Zealand. It presents information about IVF cycles undertaken in 2021 and the resulting babies born in 2021 and 2022.

The data presented in the report is managed by the National Perinatal Epidemiology and Statistics Unit (NPESU) within UNSW’s Centre for Big Data Research in Health and the School of Women’s and Children’s Health.

Key stats from the 2021 report

  • 111,253 ART treatment cycles were performed in Australian and New Zealand ART Units in 2021 (102,157 and 9,096, respectively), representing an overall increase of 16.3% from 2020.
  • Of the 111,253 initiated ART cycles, 20,690 babies were born. Of these, 18,594 (89.9%) were from treatments performed in Australian ART Units, and 2,096 (10.1%) were from New Zealand ART Units.
  • Of the 108,273 autologous and recipient cycles, 11.9% were undertaken by single female and 4.1% by female-female intending parents.
  • The proportion of births that were twins or triplets was 3%.
  • Women used their own eggs or embryos in nearly 95% of cycles in 2021; 62.3% were fresh cycles, and 37.7% were thaw cycles.
  • Over a third (37.1%) of women who commenced ART in 2018 or 2019 achieved a live birth in their first ART cycle. After three complete ART cycles, women had between 53.6% and 63% chance of achieving a live birth.
  • There were 5881 fertility preservation cycles performed in 2021, representing an increase of 61.5% from 2020.


Media contact:

Isabelle Dubach
UNSW Senior News & Content Manager 0432 307 244

More from this category

  • Medical Health Aged Care
  • 29/11/2023
  • 23:22
Clairvoyant Therapeutics

Clairvoyant Surpasses 50 Per Cent Randomization in its Phase 2b Psilocybin Therapy Trial for Alcohol Use Disorder

VANCOUVER, BC / ACCESSWIRE / November 29, 2023 / Clairvoyant Therapeutics Inc. (, the clinical-stage pharmaceutical company developing psilocybin therapy for alcohol use disorder (AUD), today announced that it has randomized more than 50 per cent of the expected 128 subjects for its 24-week Phase 2b clinical trial of synthetic psilocybin (25mg oral capsule). The double-blind, randomized controlled trial was initiated in October 2022 and is designed to assess multiple efficacy and safety endpoints."We are pleased that the pace of subject enrollment is at the upper end of our expectations. We are on track for an interim data read out…

  • Medical Health Aged Care
  • 29/11/2023
  • 12:07
Hola Health

Leading health tech firm named among fastest-growing Australian start-ups

Hola Health, a leading local health tech start-up providing telehealth and online script fulfillment services to a growing number of Australians, has been named in the top 5 fastest-growing new companies in the country in a prestigious annual list. The Australian Financial Review’s Fast Starters list recognises Australia’s 100 fastest-growing start-ups and young companies.It shows Hola Health grew revenue from around $100,000 in 2020/21 to $3.8 million last financial year. It is on track to exceed $10 million in revenue by the end of this financial year. In naming Hola Health at number five on the list, the AFR hailed…

  • Contains:
  • Medical Health Aged Care
  • 29/11/2023
  • 07:34
Public Health Association of Australia / Australian and New Zealand Journal of Public Health

New research reveals how babies and toddlers are targeted with unhealthy foods

Wednesday 29 November 2023 Babies and toddlers can't read or buy food yet, but new research reveals that they are being targeted with aggressive marketing in the baby and toddler aisle at the supermarket. The research, published today in theAustralian and New Zealand Journal of Public Health,has prompted health experts to call for regulation of on-pack labelling and promotional techniques used on baby and toddler food. Authors analysed 230 product packs found in two major supermarkets to uncover the marketing techniques used by manufacturers of products for children aged from just six months to three years. They found that 9…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time your distribute with Medianet. Pay per release or save with a subscription.